|1.||Yu, Teng: 2 articles (08/2015 - 05/2014)|
|2.||Sun, Hui: 2 articles (08/2015 - 05/2014)|
|3.||Taylor, Robert W: 2 articles (04/2007 - 04/2005)|
|4.||Hudson, Gavin: 2 articles (04/2007 - 04/2005)|
|5.||Chinnery, Patrick F: 2 articles (04/2007 - 04/2005)|
|6.||Shi, Xianhua: 1 article (08/2015)|
|7.||Meng, Jin: 1 article (08/2015)|
|8.||Sun, Yang: 1 article (08/2015)|
|9.||Chen, Chao: 1 article (08/2015)|
|10.||Li, Tian-Hang: 1 article (08/2015)|
|1.||Chronic Progressive External Ophthalmoplegia (Progressive External Ophthalmoplegia)
05/01/2002 - "A recent study showed pathogenic heterozygous missense mutations in the heart/skeletal muscle isoform of the adenine nucleotide translocator 1 gene in autosomal dominant progressive external ophthalmoplegia patients. "
04/01/2007 - "Microsatellite analysis and screening of the progressive external ophthalmoplegia 1 (PEO1), adenine nucleotide translocator 1 (ANT1), and polymerase gamma-1 (POLG1) genes. "
04/01/2005 - "Only four different mutations in the adenine nucleotide translocator 1 (ANT1) gene have been found in families with progressive external ophthalmoplegia (PEO). "
05/01/2002 - "In one Japanese autosomal dominant progressive external ophthalmoplegia family, we found a novel A-to-G heterozygous mutation at nucleotide 311 of the adenine nucleotide translocator 1 gene, which segregated with affected individuals and could not be detected in the genomic DNA sequence of 120 normal controls. "
05/01/2002 - "A novel D104G mutation in the adenine nucleotide translocator 1 gene in autosomal dominant progressive external ophthalmoplegia patients with mitochondrial DNA with multiple deletions."
08/01/2011 - "Mutations in the heart and muscle isoform of adenine nucleotide translocator 1 (ANT1) are associated with autosomal-dominant progressive external opthalmoplegia (adPEO) clinically characterized by exercise intolerance, ptosis and muscle weakness. "
01/01/2015 - "This case is unique compared to other previously reported patients with either progressive external ophthalmoplegia (PEO) or clear hypertrophic cardiomyopathy with exercise intolerance and/or muscle weakness carrying recessive mutations leading to a complete absence of the SLC25A4 protein. "
|4.||Melanoma (Melanoma, Malignant)
05/23/2014 - "In cultured WM-115 melanoma cells, curcumin induced mitochondrial membrane potential (MPP) decrease, cyclophilin-D (CyPD)-adenine nucleotide translocator 1 (ANT-1) (two mPTP components) mitochondrial association and cytochrome C release, indicating mPTP opening. "
08/14/2015 - "At the molecular level, curcumin and ABT-737 synergistically induced mitochondrial permeability transition pore (mPTP) opening in melanoma cells, the latter was evidenced by mitochondrial membrane potential (MPP) reduction and mitochondrial complexation between cyclophilin-D (CyPD) and adenine nucleotide translocator 1 (ANT-1). "
|5.||Parkinsonian Disorders (Parkinsonism)
|2.||Phosphofructokinase-1 (Phosphofructokinase 1)
|3.||Mitochondrial Proteins (Mitochondrial Protein)
|4.||1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)
|5.||Mitochondrial DNA (mtDNA)
|8.||Cytochromes c (Cytochrome c)
|10.||Messenger RNA (mRNA)